Stock comparison
AbbVie Inc. is 11.4x more valuable than TEVA PHARMACEUTICAL INDUSTRIES LTD by market capitalization ($440.14 B vs $38.54 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
ABBV is larger
AbbVie Inc. is 11.4x more valuable than TEVA PHARMACEUTICAL INDUSTRIES LTD by market capitalization ($440.14 B vs $38.54 B).
Market value leader
ABBV
AbbVie Inc. is 11.4x more valuable than TEVA PHARMACEUTICAL INDUSTRIES LTD by market capitalization ($440.14 B vs $38.54 B).
Revenue leader
ABBV
TEVA: $17.26B vs ABBV: $61.16B.
Profit leader
ABBV
TEVA: $1.41B vs ABBV: $4.23B.
Margin leader
TEVA
TEVA: 8.2% vs ABBV: 6.9% net margin.
| Metric | TEVA | ABBV |
|---|---|---|
| Market cap | $38.54 B | $440.14 B |
| US-listed rank | #396 | #25 |
| Revenue (latest FY) | $17.26B | $61.16B |
| Net income (latest FY) | $1.41B | $4.23B |
| Net margin | 8.2% | 6.9% |
| P/E (trailing FY) | 27.3x | 104.2x |
| SEC filings | 2,473 | 1,008 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AbbVie Inc. is 11.4x more valuable than TEVA PHARMACEUTICAL INDUSTRIES LTD by market capitalization ($440.14 B vs $38.54 B).
In their latest fiscal years, TEVA PHARMACEUTICAL INDUSTRIES LTD reported $17.26B in revenue while AbbVie Inc. reported $61.16B.
Full pages: TEVA PHARMACEUTICAL INDUSTRIES LTD and AbbVie Inc., or browse the full rankings.